Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production.

about

Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer.

P2860

Q54939968-949FB03B-9FB9-4840-A824-833F600B1BE6

P2860

Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production.

Item

http://www.wikidata.org/entity/Q40566789

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Celecoxib enhances the inhibit ...... oliferation by ROS production.

@en

type

Item

label

Celecoxib enhances the inhibit ...... oliferation by ROS production.

@en

prefLabel

Celecoxib enhances the inhibit ...... oliferation by ROS production.

@en

P1476

Celecoxib enhances the inhibit ...... oliferation by ROS production.

@en

P2093

Doh Young Lee

http://www.w3.org/2001/XMLSchema#string

Eun Sil Shin

http://www.w3.org/2001/XMLSchema#string

Jun-Jae Choi

http://www.w3.org/2001/XMLSchema#string

Myung-Whun Sung

http://www.w3.org/2001/XMLSchema#string

Sang-Mi Oh

http://www.w3.org/2001/XMLSchema#string

Seok-Woo Park

http://www.w3.org/2001/XMLSchema#string

Seong Keun Kwon

http://www.w3.org/2001/XMLSchema#string

Soon-Hyun Ahn

http://www.w3.org/2001/XMLSchema#string

Young Ho Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions

Physiological functions of protein kinase B/Akt

Live or let die: the cell's response to p53

In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter

Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.

AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.

The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells.

p53 polymorphisms: cancer implications.

Targeting apoptosis pathways by Celecoxib in cancer.

Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.

P304

E117-E123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LARY.26309

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27666139

http://www.w3.org/2001/XMLSchema#string

Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production.

about

P2860

P2860

Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698